nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—MPO—Calcipotriol—psoriasis	0.225	0.345	CbGbCtD
Cisplatin—CYP4A11—Dexamethasone—psoriasis	0.0542	0.083	CbGbCtD
Cisplatin—ABCC3—Cyclosporine—psoriasis	0.0395	0.0606	CbGbCtD
Cisplatin—BCHE—Triamcinolone—psoriasis	0.0305	0.0467	CbGbCtD
Cisplatin—ABCC2—Mycophenolate mofetil—psoriasis	0.0237	0.0363	CbGbCtD
Cisplatin—PTGS2—Triamcinolone—psoriasis	0.0234	0.0359	CbGbCtD
Cisplatin—ABCG2—Mycophenolate mofetil—psoriasis	0.0214	0.0328	CbGbCtD
Cisplatin—ABCC3—Methotrexate—psoriasis	0.0209	0.0321	CbGbCtD
Cisplatin—PTGS2—Betamethasone—psoriasis	0.0201	0.0308	CbGbCtD
Cisplatin—ABCC2—Cyclosporine—psoriasis	0.018	0.0275	CbGbCtD
Cisplatin—CYP2B6—Cholecalciferol—psoriasis	0.0174	0.0266	CbGbCtD
Cisplatin—ABCG2—Hydrocortisone—psoriasis	0.0172	0.0264	CbGbCtD
Cisplatin—ABCG2—Cyclosporine—psoriasis	0.0162	0.0249	CbGbCtD
Cisplatin—ABCC2—Dexamethasone—psoriasis	0.0118	0.0181	CbGbCtD
Cisplatin—PTGS2—Dexamethasone—psoriasis	0.0117	0.0179	CbGbCtD
Cisplatin—ABCG2—Dexamethasone—psoriasis	0.0107	0.0164	CbGbCtD
Cisplatin—ABCC6—dermis—psoriasis	0.0105	0.293	CbGeAlD
Cisplatin—ABCC2—Methotrexate—psoriasis	0.00951	0.0146	CbGbCtD
Cisplatin—CYP2C9—Cholecalciferol—psoriasis	0.00918	0.0141	CbGbCtD
Cisplatin—ABCG2—Methotrexate—psoriasis	0.0086	0.0132	CbGbCtD
Cisplatin—ABCB1—Mycophenolate mofetil—psoriasis	0.00773	0.0118	CbGbCtD
Cisplatin—CYP2B6—Dexamethasone—psoriasis	0.00752	0.0115	CbGbCtD
Cisplatin—ABCB1—Betamethasone—psoriasis	0.00663	0.0102	CbGbCtD
Cisplatin—ABCB1—Prednisolone—psoriasis	0.00654	0.01	CbGbCtD
Cisplatin—ABCB1—Hydrocortisone—psoriasis	0.0062	0.0095	CbGbCtD
Cisplatin—ABCB1—Prednisone—psoriasis	0.00618	0.00947	CbGbCtD
Cisplatin—CYP2C9—Cyclosporine—psoriasis	0.00604	0.00925	CbGbCtD
Cisplatin—ABCB1—Cyclosporine—psoriasis	0.00586	0.00898	CbGbCtD
Cisplatin—CYP2C9—Dexamethasone—psoriasis	0.00397	0.00609	CbGbCtD
Cisplatin—ABCB1—Dexamethasone—psoriasis	0.00386	0.00591	CbGbCtD
Cisplatin—ATP7A—endothelium—psoriasis	0.00351	0.0974	CbGeAlD
Cisplatin—ABCB1—Methotrexate—psoriasis	0.0031	0.00475	CbGbCtD
Cisplatin—PTGS2—skeletal joint—psoriasis	0.00241	0.067	CbGeAlD
Cisplatin—MPO—endothelium—psoriasis	0.00188	0.0522	CbGeAlD
Cisplatin—PTGS2—synovial membrane of synovial joint—psoriasis	0.00183	0.0509	CbGeAlD
Cisplatin—MT2A—skin of body—psoriasis	0.00173	0.048	CbGeAlD
Cisplatin—SLC31A2—tendon—psoriasis	0.00129	0.0359	CbGeAlD
Cisplatin—GSTM1—skin of body—psoriasis	0.00125	0.0346	CbGeAlD
Cisplatin—PTGS2—skin epidermis—psoriasis	0.00118	0.0326	CbGeAlD
Cisplatin—ATP7A—tendon—psoriasis	0.00114	0.0316	CbGeAlD
Cisplatin—SOD1—tendon—psoriasis	0.000997	0.0277	CbGeAlD
Cisplatin—SLC31A1—tendon—psoriasis	0.000972	0.027	CbGeAlD
Cisplatin—NQO1—skin of body—psoriasis	0.000873	0.0243	CbGeAlD
Cisplatin—PTGS2—endothelium—psoriasis	0.000853	0.0237	CbGeAlD
Cisplatin—MPO—skin of body—psoriasis	0.000803	0.0223	CbGeAlD
Cisplatin—GSTP1—skin of body—psoriasis	0.000781	0.0217	CbGeAlD
Cisplatin—ABCC5—tendon—psoriasis	0.000711	0.0197	CbGeAlD
Cisplatin—NQO1—tendon—psoriasis	0.000665	0.0185	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000613	0.157	CbGdCrCtD
Cisplatin—GSTP1—tendon—psoriasis	0.000594	0.0165	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000491	0.126	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000477	0.122	CbGdCrCtD
Cisplatin—ABCC2—tendon—psoriasis	0.000477	0.0132	CbGeAlD
Cisplatin—BCHE—skin of body—psoriasis	0.000473	0.0131	CbGeAlD
Cisplatin—CYP2B6—skin of body—psoriasis	0.000421	0.0117	CbGeAlD
Cisplatin—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00037	0.0949	CbGdCrCtD
Cisplatin—PTGS2—skin of body—psoriasis	0.000364	0.0101	CbGeAlD
Cisplatin—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000296	0.076	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000296	0.076	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000288	0.0738	CbGdCrCtD
Cisplatin—PTGS2—tendon—psoriasis	0.000277	0.0077	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000224	0.0574	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000224	0.0574	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000219	0.0561	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	0.000135	0.0346	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	0.000135	0.0346	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	0.000132	0.0338	CbGdCrCtD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	0.000103	0.00101	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL13—psoriasis	0.000103	0.00101	CbGpPWpGaD
Cisplatin—BCHE—Peptide hormone metabolism—LEP—psoriasis	0.000103	0.001	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFIH1—psoriasis	0.000101	0.000987	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000101	0.000983	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—NFKB1—psoriasis	9.97e-05	0.000972	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL6—psoriasis	9.97e-05	0.000972	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—TNF—psoriasis	9.81e-05	0.000956	CbGpPWpGaD
Cisplatin—Alopecia—Betamethasone—psoriasis	9.74e-05	0.000475	CcSEcCtD
Cisplatin—Alopecia—Dexamethasone—psoriasis	9.74e-05	0.000475	CcSEcCtD
Cisplatin—Convulsion—Hydrocortisone—psoriasis	9.73e-05	0.000475	CcSEcCtD
Cisplatin—Hyperhidrosis—Mycophenolate mofetil—psoriasis	9.73e-05	0.000475	CcSEcCtD
Cisplatin—Vomiting—Hydroxyurea—psoriasis	9.68e-05	0.000472	CcSEcCtD
Cisplatin—Discomfort—Prednisolone—psoriasis	9.67e-05	0.000472	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—psoriasis	9.61e-05	0.000469	CcSEcCtD
Cisplatin—MT2A—Immune System—HLA-C—psoriasis	9.6e-05	0.000936	CbGpPWpGaD
Cisplatin—Rash—Hydroxyurea—psoriasis	9.6e-05	0.000468	CcSEcCtD
Cisplatin—Erythema—Dexamethasone—psoriasis	9.6e-05	0.000468	CcSEcCtD
Cisplatin—Erythema—Betamethasone—psoriasis	9.6e-05	0.000468	CcSEcCtD
Cisplatin—Anorexia—Mycophenolate mofetil—psoriasis	9.59e-05	0.000468	CcSEcCtD
Cisplatin—Dermatitis—Hydroxyurea—psoriasis	9.59e-05	0.000468	CcSEcCtD
Cisplatin—Myalgia—Hydrocortisone—psoriasis	9.56e-05	0.000467	CcSEcCtD
Cisplatin—Malaise—Triamcinolone—psoriasis	9.54e-05	0.000465	CcSEcCtD
Cisplatin—Anxiety—Hydrocortisone—psoriasis	9.53e-05	0.000465	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL17A—psoriasis	9.52e-05	0.000928	CbGpPWpGaD
Cisplatin—Pancytopenia—Methotrexate—psoriasis	9.52e-05	0.000465	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	9.5e-05	0.000463	CcSEcCtD
Cisplatin—MT2A—Immune System—TNFAIP3—psoriasis	9.49e-05	0.000925	CbGpPWpGaD
Cisplatin—Discomfort—Hydrocortisone—psoriasis	9.45e-05	0.000461	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	9.43e-05	0.00092	CbGpPWpGaD
Cisplatin—Connective tissue disorder—Prednisone—psoriasis	9.43e-05	0.00046	CcSEcCtD
Cisplatin—Hypotension—Mycophenolate mofetil—psoriasis	9.4e-05	0.000459	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Cyclosporine—psoriasis	9.4e-05	0.000459	CcSEcCtD
Cisplatin—Oedema—Prednisolone—psoriasis	9.39e-05	0.000458	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisolone—psoriasis	9.39e-05	0.000458	CcSEcCtD
Cisplatin—XDH—Metabolism—NDUFA5—psoriasis	9.35e-05	0.000911	CbGpPWpGaD
Cisplatin—Paraesthesia—Cyclosporine—psoriasis	9.26e-05	0.000452	CcSEcCtD
Cisplatin—Dyspnoea—Cyclosporine—psoriasis	9.2e-05	0.000449	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	9.17e-05	0.000447	CcSEcCtD
Cisplatin—Oedema—Hydrocortisone—psoriasis	9.17e-05	0.000447	CcSEcCtD
Cisplatin—Anaphylactic shock—Hydrocortisone—psoriasis	9.17e-05	0.000447	CcSEcCtD
Cisplatin—Convulsion—Triamcinolone—psoriasis	9.16e-05	0.000447	CcSEcCtD
Cisplatin—Tachycardia—Prednisolone—psoriasis	9.16e-05	0.000447	CcSEcCtD
Cisplatin—Asthenia—Mycophenolic acid—psoriasis	9.15e-05	0.000446	CcSEcCtD
Cisplatin—Infection—Hydrocortisone—psoriasis	9.11e-05	0.000444	CcSEcCtD
Cisplatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.11e-05	0.000888	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CYP2S1—psoriasis	9.09e-05	0.000886	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IL6—psoriasis	9.08e-05	0.000885	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Prednisolone—psoriasis	9.07e-05	0.000443	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—VEGFA—psoriasis	9.05e-05	0.000882	CbGpPWpGaD
Cisplatin—Nausea—Hydroxyurea—psoriasis	9.04e-05	0.000441	CcSEcCtD
Cisplatin—Paraesthesia—Mycophenolate mofetil—psoriasis	9.03e-05	0.000441	CcSEcCtD
Cisplatin—Myalgia—Triamcinolone—psoriasis	9e-05	0.000439	CcSEcCtD
Cisplatin—Nervous system disorder—Hydrocortisone—psoriasis	8.99e-05	0.000439	CcSEcCtD
Cisplatin—Eye disorder—Prednisone—psoriasis	8.97e-05	0.000438	CcSEcCtD
Cisplatin—Dyspnoea—Mycophenolate mofetil—psoriasis	8.97e-05	0.000438	CcSEcCtD
Cisplatin—Decreased appetite—Cyclosporine—psoriasis	8.97e-05	0.000438	CcSEcCtD
Cisplatin—ABCC5—Metabolism—NDUFA5—psoriasis	8.96e-05	0.000873	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—STAT3—psoriasis	8.96e-05	0.000873	CbGpPWpGaD
Cisplatin—Tachycardia—Hydrocortisone—psoriasis	8.95e-05	0.000437	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—NFKB1—psoriasis	8.94e-05	0.000872	CbGpPWpGaD
Cisplatin—Flushing—Prednisone—psoriasis	8.91e-05	0.000435	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Cyclosporine—psoriasis	8.9e-05	0.000435	CcSEcCtD
Cisplatin—Skin disorder—Hydrocortisone—psoriasis	8.9e-05	0.000435	CcSEcCtD
Cisplatin—Ill-defined disorder—Betamethasone—psoriasis	8.9e-05	0.000434	CcSEcCtD
Cisplatin—Ill-defined disorder—Dexamethasone—psoriasis	8.9e-05	0.000434	CcSEcCtD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	8.9e-05	0.000868	CbGpPWpGaD
Cisplatin—Discomfort—Triamcinolone—psoriasis	8.9e-05	0.000434	CcSEcCtD
Cisplatin—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	8.87e-05	0.000864	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Hydrocortisone—psoriasis	8.86e-05	0.000432	CcSEcCtD
Cisplatin—NQO1—Metabolism—CYP2S1—psoriasis	8.86e-05	0.000864	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL12B—psoriasis	8.85e-05	0.000863	CbGpPWpGaD
Cisplatin—Pain—Cyclosporine—psoriasis	8.82e-05	0.00043	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—psoriasis	8.79e-05	0.000429	CcSEcCtD
Cisplatin—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	8.77e-05	0.000855	CbGpPWpGaD
Cisplatin—Decreased appetite—Mycophenolate mofetil—psoriasis	8.75e-05	0.000427	CcSEcCtD
Cisplatin—Anorexia—Hydrocortisone—psoriasis	8.74e-05	0.000426	CcSEcCtD
Cisplatin—Diarrhoea—Mycophenolic acid—psoriasis	8.72e-05	0.000426	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—psoriasis	8.71e-05	0.000425	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—psoriasis	8.69e-05	0.000424	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	8.69e-05	0.000424	CcSEcCtD
Cisplatin—Immune system disorder—Prednisone—psoriasis	8.67e-05	0.000423	CcSEcCtD
Cisplatin—Malaise—Dexamethasone—psoriasis	8.65e-05	0.000422	CcSEcCtD
Cisplatin—Malaise—Betamethasone—psoriasis	8.65e-05	0.000422	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.64e-05	0.000842	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Triamcinolone—psoriasis	8.63e-05	0.000421	CcSEcCtD
Cisplatin—Oedema—Triamcinolone—psoriasis	8.63e-05	0.000421	CcSEcCtD
Cisplatin—Pain—Mycophenolate mofetil—psoriasis	8.6e-05	0.00042	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—TNF—psoriasis	8.58e-05	0.000836	CbGpPWpGaD
Cisplatin—Arrhythmia—Prednisone—psoriasis	8.58e-05	0.000419	CcSEcCtD
Cisplatin—Infection—Triamcinolone—psoriasis	8.57e-05	0.000418	CcSEcCtD
Cisplatin—Hypotension—Hydrocortisone—psoriasis	8.57e-05	0.000418	CcSEcCtD
Cisplatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.51e-05	0.000829	CbGpPWpGaD
Cisplatin—Feeling abnormal—Cyclosporine—psoriasis	8.5e-05	0.000415	CcSEcCtD
Cisplatin—Alopecia—Prednisone—psoriasis	8.48e-05	0.000414	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—psoriasis	8.45e-05	0.000412	CcSEcCtD
Cisplatin—Paraesthesia—Prednisolone—psoriasis	8.43e-05	0.000411	CcSEcCtD
Cisplatin—Tachycardia—Triamcinolone—psoriasis	8.42e-05	0.000411	CcSEcCtD
Cisplatin—Erythema—Prednisone—psoriasis	8.36e-05	0.000408	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—psoriasis	8.36e-05	0.000408	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.35e-05	0.000408	CcSEcCtD
Cisplatin—Hyperhidrosis—Triamcinolone—psoriasis	8.34e-05	0.000407	CcSEcCtD
Cisplatin—ABCC5—Transmembrane transport of small molecules—CP—psoriasis	8.33e-05	0.000812	CbGpPWpGaD
Cisplatin—Convulsion—Dexamethasone—psoriasis	8.31e-05	0.000406	CcSEcCtD
Cisplatin—Convulsion—Betamethasone—psoriasis	8.31e-05	0.000406	CcSEcCtD
Cisplatin—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.29e-05	0.000405	CcSEcCtD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	8.24e-05	0.000804	CbGpPWpGaD
Cisplatin—Paraesthesia—Hydrocortisone—psoriasis	8.23e-05	0.000402	CcSEcCtD
Cisplatin—Myalgia—Dexamethasone—psoriasis	8.17e-05	0.000399	CcSEcCtD
Cisplatin—Myalgia—Betamethasone—psoriasis	8.17e-05	0.000399	CcSEcCtD
Cisplatin—Body temperature increased—Cyclosporine—psoriasis	8.15e-05	0.000398	CcSEcCtD
Cisplatin—Anxiety—Dexamethasone—psoriasis	8.14e-05	0.000397	CcSEcCtD
Cisplatin—Anxiety—Betamethasone—psoriasis	8.14e-05	0.000397	CcSEcCtD
Cisplatin—Vomiting—Mycophenolic acid—psoriasis	8.11e-05	0.000396	CcSEcCtD
Cisplatin—GSTT1—Metabolism—CARM1—psoriasis	8.1e-05	0.00079	CbGpPWpGaD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	8.08e-05	0.000787	CbGpPWpGaD
Cisplatin—Discomfort—Betamethasone—psoriasis	8.07e-05	0.000394	CcSEcCtD
Cisplatin—Discomfort—Dexamethasone—psoriasis	8.07e-05	0.000394	CcSEcCtD
Cisplatin—Rash—Mycophenolic acid—psoriasis	8.04e-05	0.000392	CcSEcCtD
Cisplatin—MT2A—Cytokine Signaling in Immune system—STAT3—psoriasis	8.04e-05	0.000783	CbGpPWpGaD
Cisplatin—Dermatitis—Mycophenolic acid—psoriasis	8.03e-05	0.000392	CcSEcCtD
Cisplatin—Pain—Prednisolone—psoriasis	8.03e-05	0.000392	CcSEcCtD
Cisplatin—MT2A—Immune System—HLA-E—psoriasis	7.97e-05	0.000777	CbGpPWpGaD
Cisplatin—Decreased appetite—Hydrocortisone—psoriasis	7.97e-05	0.000389	CcSEcCtD
Cisplatin—Body temperature increased—Mycophenolate mofetil—psoriasis	7.95e-05	0.000388	CcSEcCtD
Cisplatin—XDH—Metabolism—CYP2S1—psoriasis	7.95e-05	0.000775	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—CARM1—psoriasis	7.94e-05	0.000774	CbGpPWpGaD
Cisplatin—Urinary tract disorder—Methotrexate—psoriasis	7.92e-05	0.000387	CcSEcCtD
Cisplatin—MPO—Selenium Micronutrient Network—IL6—psoriasis	7.92e-05	0.000772	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.91e-05	0.000386	CcSEcCtD
Cisplatin—Vision blurred—Prednisone—psoriasis	7.88e-05	0.000384	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—psoriasis	7.86e-05	0.000384	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.86e-05	0.000384	CcSEcCtD
Cisplatin—Pain—Hydrocortisone—psoriasis	7.84e-05	0.000383	CcSEcCtD
Cisplatin—Oedema—Dexamethasone—psoriasis	7.83e-05	0.000382	CcSEcCtD
Cisplatin—Oedema—Betamethasone—psoriasis	7.83e-05	0.000382	CcSEcCtD
Cisplatin—Anaphylactic shock—Dexamethasone—psoriasis	7.83e-05	0.000382	CcSEcCtD
Cisplatin—Anaphylactic shock—Betamethasone—psoriasis	7.83e-05	0.000382	CcSEcCtD
Cisplatin—Infection—Betamethasone—psoriasis	7.78e-05	0.00038	CcSEcCtD
Cisplatin—Infection—Dexamethasone—psoriasis	7.78e-05	0.00038	CcSEcCtD
Cisplatin—CYP4A11—Metabolism—NDUFA5—psoriasis	7.77e-05	0.000757	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Prednisone—psoriasis	7.75e-05	0.000378	CcSEcCtD
Cisplatin—Paraesthesia—Triamcinolone—psoriasis	7.75e-05	0.000378	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	7.74e-05	0.000755	CbGpPWpGaD
Cisplatin—Feeling abnormal—Prednisolone—psoriasis	7.73e-05	0.000377	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—psoriasis	7.73e-05	0.000377	CcSEcCtD
Cisplatin—Anaemia—Prednisone—psoriasis	7.72e-05	0.000377	CcSEcCtD
Cisplatin—Dyspnoea—Triamcinolone—psoriasis	7.7e-05	0.000376	CcSEcCtD
Cisplatin—Nervous system disorder—Dexamethasone—psoriasis	7.68e-05	0.000375	CcSEcCtD
Cisplatin—Nervous system disorder—Betamethasone—psoriasis	7.68e-05	0.000375	CcSEcCtD
Cisplatin—Thrombocytopenia—Dexamethasone—psoriasis	7.67e-05	0.000374	CcSEcCtD
Cisplatin—Thrombocytopenia—Betamethasone—psoriasis	7.67e-05	0.000374	CcSEcCtD
Cisplatin—Tachycardia—Dexamethasone—psoriasis	7.64e-05	0.000373	CcSEcCtD
Cisplatin—Tachycardia—Betamethasone—psoriasis	7.64e-05	0.000373	CcSEcCtD
Cisplatin—ABCC5—Metabolism—CYP2S1—psoriasis	7.62e-05	0.000743	CbGpPWpGaD
Cisplatin—Hypersensitivity—Cyclosporine—psoriasis	7.6e-05	0.000371	CcSEcCtD
Cisplatin—Nausea—Mycophenolic acid—psoriasis	7.57e-05	0.00037	CcSEcCtD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	7.57e-05	0.000738	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Betamethasone—psoriasis	7.57e-05	0.000369	CcSEcCtD
Cisplatin—Hyperhidrosis—Dexamethasone—psoriasis	7.57e-05	0.000369	CcSEcCtD
Cisplatin—Feeling abnormal—Hydrocortisone—psoriasis	7.55e-05	0.000369	CcSEcCtD
Cisplatin—Malaise—Prednisone—psoriasis	7.54e-05	0.000368	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—psoriasis	7.5e-05	0.000366	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—psoriasis	7.48e-05	0.000365	CcSEcCtD
Cisplatin—Anorexia—Dexamethasone—psoriasis	7.47e-05	0.000364	CcSEcCtD
Cisplatin—Anorexia—Betamethasone—psoriasis	7.47e-05	0.000364	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—psoriasis	7.45e-05	0.000363	CcSEcCtD
Cisplatin—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.41e-05	0.000362	CcSEcCtD
Cisplatin—Asthenia—Cyclosporine—psoriasis	7.4e-05	0.000361	CcSEcCtD
Cisplatin—Pain—Triamcinolone—psoriasis	7.38e-05	0.00036	CcSEcCtD
Cisplatin—Hypotension—Betamethasone—psoriasis	7.32e-05	0.000357	CcSEcCtD
Cisplatin—Hypotension—Dexamethasone—psoriasis	7.32e-05	0.000357	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—psoriasis	7.25e-05	0.000354	CcSEcCtD
Cisplatin—Body temperature increased—Hydrocortisone—psoriasis	7.25e-05	0.000354	CcSEcCtD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.24e-05	0.000706	CbGpPWpGaD
Cisplatin—Convulsion—Prednisone—psoriasis	7.24e-05	0.000353	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—psoriasis	7.23e-05	0.000353	CcSEcCtD
Cisplatin—Asthenia—Mycophenolate mofetil—psoriasis	7.22e-05	0.000352	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	7.2e-05	0.000702	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.15e-05	0.000697	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.14e-05	0.000348	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Betamethasone—psoriasis	7.14e-05	0.000348	CcSEcCtD
Cisplatin—Myalgia—Prednisone—psoriasis	7.11e-05	0.000347	CcSEcCtD
Cisplatin—Feeling abnormal—Triamcinolone—psoriasis	7.11e-05	0.000347	CcSEcCtD
Cisplatin—Anxiety—Prednisone—psoriasis	7.09e-05	0.000346	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—psoriasis	7.09e-05	0.000346	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.07e-05	0.000345	CcSEcCtD
Cisplatin—Diarrhoea—Cyclosporine—psoriasis	7.06e-05	0.000344	CcSEcCtD
Cisplatin—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	7.04e-05	0.000686	CbGpPWpGaD
Cisplatin—Paraesthesia—Dexamethasone—psoriasis	7.03e-05	0.000343	CcSEcCtD
Cisplatin—Paraesthesia—Betamethasone—psoriasis	7.03e-05	0.000343	CcSEcCtD
Cisplatin—Discomfort—Prednisone—psoriasis	7.03e-05	0.000343	CcSEcCtD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	7.03e-05	0.000685	CbGpPWpGaD
Cisplatin—Malnutrition—Methotrexate—psoriasis	6.98e-05	0.000341	CcSEcCtD
Cisplatin—Erythema—Methotrexate—psoriasis	6.98e-05	0.000341	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—IL6—psoriasis	6.92e-05	0.000675	CbGpPWpGaD
Cisplatin—Hypersensitivity—Prednisolone—psoriasis	6.92e-05	0.000337	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.89e-05	0.000671	CbGpPWpGaD
Cisplatin—Diarrhoea—Mycophenolate mofetil—psoriasis	6.88e-05	0.000336	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—TP53—psoriasis	6.84e-05	0.000667	CbGpPWpGaD
Cisplatin—Body temperature increased—Triamcinolone—psoriasis	6.82e-05	0.000333	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—psoriasis	6.82e-05	0.000333	CcSEcCtD
Cisplatin—Oedema—Prednisone—psoriasis	6.82e-05	0.000333	CcSEcCtD
Cisplatin—Decreased appetite—Dexamethasone—psoriasis	6.81e-05	0.000332	CcSEcCtD
Cisplatin—Decreased appetite—Betamethasone—psoriasis	6.81e-05	0.000332	CcSEcCtD
Cisplatin—Infection—Prednisone—psoriasis	6.78e-05	0.000331	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Dexamethasone—psoriasis	6.76e-05	0.00033	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Betamethasone—psoriasis	6.76e-05	0.00033	CcSEcCtD
Cisplatin—Hypersensitivity—Hydrocortisone—psoriasis	6.75e-05	0.00033	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—CXCL8—psoriasis	6.71e-05	0.000654	CbGpPWpGaD
Cisplatin—Pain—Betamethasone—psoriasis	6.7e-05	0.000327	CcSEcCtD
Cisplatin—Pain—Dexamethasone—psoriasis	6.7e-05	0.000327	CcSEcCtD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	6.69e-05	0.000652	CbGpPWpGaD
Cisplatin—Nervous system disorder—Prednisone—psoriasis	6.69e-05	0.000326	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—psoriasis	6.66e-05	0.000325	CcSEcCtD
Cisplatin—MT2A—Immune System—SOCS1—psoriasis	6.66e-05	0.000649	CbGpPWpGaD
Cisplatin—Skin disorder—Prednisone—psoriasis	6.62e-05	0.000323	CcSEcCtD
Cisplatin—CYP4A11—Metabolism—CYP2S1—psoriasis	6.61e-05	0.000644	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—NDUFA5—psoriasis	6.61e-05	0.000644	CbGpPWpGaD
Cisplatin—Hyperhidrosis—Prednisone—psoriasis	6.59e-05	0.000322	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—psoriasis	6.58e-05	0.000321	CcSEcCtD
Cisplatin—Asthenia—Hydrocortisone—psoriasis	6.58e-05	0.000321	CcSEcCtD
Cisplatin—Vomiting—Cyclosporine—psoriasis	6.56e-05	0.00032	CcSEcCtD
Cisplatin—Rash—Cyclosporine—psoriasis	6.5e-05	0.000317	CcSEcCtD
Cisplatin—Anorexia—Prednisone—psoriasis	6.5e-05	0.000317	CcSEcCtD
Cisplatin—Dermatitis—Cyclosporine—psoriasis	6.5e-05	0.000317	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—psoriasis	6.48e-05	0.000316	CcSEcCtD
Cisplatin—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	6.47e-05	0.000631	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL10—psoriasis	6.47e-05	0.000631	CbGpPWpGaD
Cisplatin—Anaemia—Methotrexate—psoriasis	6.46e-05	0.000315	CcSEcCtD
Cisplatin—Feeling abnormal—Betamethasone—psoriasis	6.45e-05	0.000315	CcSEcCtD
Cisplatin—Feeling abnormal—Dexamethasone—psoriasis	6.45e-05	0.000315	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—IL4—psoriasis	6.44e-05	0.000628	CbGpPWpGaD
Cisplatin—Vomiting—Mycophenolate mofetil—psoriasis	6.4e-05	0.000312	CcSEcCtD
Cisplatin—Hypersensitivity—Triamcinolone—psoriasis	6.36e-05	0.00031	CcSEcCtD
Cisplatin—Rash—Mycophenolate mofetil—psoriasis	6.34e-05	0.00031	CcSEcCtD
Cisplatin—Dermatitis—Mycophenolate mofetil—psoriasis	6.34e-05	0.000309	CcSEcCtD
Cisplatin—Malaise—Methotrexate—psoriasis	6.3e-05	0.000307	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—IL4—psoriasis	6.3e-05	0.000614	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—psoriasis	6.28e-05	0.000612	CbGpPWpGaD
Cisplatin—Diarrhoea—Hydrocortisone—psoriasis	6.27e-05	0.000306	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—IL6—psoriasis	6.26e-05	0.00061	CbGpPWpGaD
Cisplatin—Leukopenia—Methotrexate—psoriasis	6.25e-05	0.000305	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.25e-05	0.000609	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—JUN—psoriasis	6.24e-05	0.000608	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Prednisone—psoriasis	6.21e-05	0.000303	CcSEcCtD
Cisplatin—Asthenia—Triamcinolone—psoriasis	6.19e-05	0.000302	CcSEcCtD
Cisplatin—Body temperature increased—Betamethasone—psoriasis	6.19e-05	0.000302	CcSEcCtD
Cisplatin—Body temperature increased—Dexamethasone—psoriasis	6.19e-05	0.000302	CcSEcCtD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.16e-05	0.0006	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.16e-05	0.0006	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.15e-05	0.000599	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—CP—psoriasis	6.14e-05	0.000598	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	6.14e-05	0.000598	CbGpPWpGaD
Cisplatin—Nausea—Cyclosporine—psoriasis	6.13e-05	0.000299	CcSEcCtD
Cisplatin—Paraesthesia—Prednisone—psoriasis	6.12e-05	0.000299	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—psoriasis	6.05e-05	0.000295	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—NFKB1—psoriasis	6e-05	0.000585	CbGpPWpGaD
Cisplatin—Nausea—Mycophenolate mofetil—psoriasis	5.98e-05	0.000292	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—psoriasis	5.95e-05	0.00029	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—psoriasis	5.93e-05	0.000289	CcSEcCtD
Cisplatin—Rash—Prednisolone—psoriasis	5.92e-05	0.000289	CcSEcCtD
Cisplatin—Dermatitis—Prednisolone—psoriasis	5.91e-05	0.000289	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.91e-05	0.000288	CcSEcCtD
Cisplatin—MT2A—Immune System—CD8A—psoriasis	5.9e-05	0.000575	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	5.88e-05	0.000573	CbGpPWpGaD
Cisplatin—Discomfort—Methotrexate—psoriasis	5.87e-05	0.000287	CcSEcCtD
Cisplatin—ABCC3—Transmembrane transport of small molecules—CARM1—psoriasis	5.86e-05	0.000571	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CXCL8—psoriasis	5.85e-05	0.000571	CbGpPWpGaD
Cisplatin—Vomiting—Hydrocortisone—psoriasis	5.83e-05	0.000284	CcSEcCtD
Cisplatin—Rash—Hydrocortisone—psoriasis	5.78e-05	0.000282	CcSEcCtD
Cisplatin—Dermatitis—Hydrocortisone—psoriasis	5.77e-05	0.000282	CcSEcCtD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.73e-05	0.000559	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.7e-05	0.000556	CbGpPWpGaD
Cisplatin—Anaphylactic shock—Methotrexate—psoriasis	5.7e-05	0.000278	CcSEcCtD
Cisplatin—MT2A—Immune System—HLA-B—psoriasis	5.68e-05	0.000554	CbGpPWpGaD
Cisplatin—Infection—Methotrexate—psoriasis	5.66e-05	0.000276	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—psoriasis	5.62e-05	0.000274	CcSEcCtD
Cisplatin—Asthenia—Dexamethasone—psoriasis	5.62e-05	0.000274	CcSEcCtD
Cisplatin—Asthenia—Betamethasone—psoriasis	5.62e-05	0.000274	CcSEcCtD
Cisplatin—ABCC3—Metabolism—CYP2S1—psoriasis	5.62e-05	0.000548	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL6—psoriasis	5.61e-05	0.000547	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NOS2—psoriasis	5.59e-05	0.000545	CbGpPWpGaD
Cisplatin—Nervous system disorder—Methotrexate—psoriasis	5.59e-05	0.000273	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—psoriasis	5.58e-05	0.000272	CcSEcCtD
Cisplatin—Nausea—Prednisolone—psoriasis	5.58e-05	0.000272	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—psoriasis	5.54e-05	0.00027	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—psoriasis	5.51e-05	0.000269	CcSEcCtD
Cisplatin—Vomiting—Triamcinolone—psoriasis	5.49e-05	0.000268	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—LEP—psoriasis	5.45e-05	0.000531	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—VEGFA—psoriasis	5.45e-05	0.000531	CbGpPWpGaD
Cisplatin—Nausea—Hydrocortisone—psoriasis	5.44e-05	0.000266	CcSEcCtD
Cisplatin—Rash—Triamcinolone—psoriasis	5.44e-05	0.000266	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—JUN—psoriasis	5.44e-05	0.00053	CbGpPWpGaD
Cisplatin—Dermatitis—Triamcinolone—psoriasis	5.44e-05	0.000265	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—psoriasis	5.43e-05	0.000265	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—STAT3—psoriasis	5.39e-05	0.000526	CbGpPWpGaD
Cisplatin—Body temperature increased—Prednisone—psoriasis	5.39e-05	0.000263	CcSEcCtD
Cisplatin—Diarrhoea—Betamethasone—psoriasis	5.36e-05	0.000261	CcSEcCtD
Cisplatin—Diarrhoea—Dexamethasone—psoriasis	5.36e-05	0.000261	CcSEcCtD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.36e-05	0.000522	CbGpPWpGaD
Cisplatin—Hypotension—Methotrexate—psoriasis	5.33e-05	0.00026	CcSEcCtD
Cisplatin—MT2A—Immune System—HLA-A—psoriasis	5.26e-05	0.000513	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—NFKB1—psoriasis	5.24e-05	0.000511	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CARM1—psoriasis	5.22e-05	0.000509	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.21e-05	0.000508	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Methotrexate—psoriasis	5.19e-05	0.000253	CcSEcCtD
Cisplatin—Nausea—Triamcinolone—psoriasis	5.13e-05	0.00025	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	5.12e-05	0.000499	CbGpPWpGaD
Cisplatin—Paraesthesia—Methotrexate—psoriasis	5.12e-05	0.00025	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—psoriasis	5.08e-05	0.000248	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—NOS2—psoriasis	5.08e-05	0.000495	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—NDUFA5—psoriasis	5.05e-05	0.000492	CbGpPWpGaD
Cisplatin—Hypersensitivity—Prednisone—psoriasis	5.02e-05	0.000245	CcSEcCtD
Cisplatin—MT2A—Immune System—CRP—psoriasis	5.02e-05	0.000489	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—REN—psoriasis	5.01e-05	0.000489	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	5.01e-05	0.000488	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—CAT—psoriasis	4.98e-05	0.000486	CbGpPWpGaD
Cisplatin—Vomiting—Betamethasone—psoriasis	4.98e-05	0.000243	CcSEcCtD
Cisplatin—Vomiting—Dexamethasone—psoriasis	4.98e-05	0.000243	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—psoriasis	4.95e-05	0.000242	CcSEcCtD
Cisplatin—Rash—Betamethasone—psoriasis	4.94e-05	0.000241	CcSEcCtD
Cisplatin—Rash—Dexamethasone—psoriasis	4.94e-05	0.000241	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—CD4—psoriasis	4.94e-05	0.000481	CbGpPWpGaD
Cisplatin—Dermatitis—Betamethasone—psoriasis	4.93e-05	0.000241	CcSEcCtD
Cisplatin—Dermatitis—Dexamethasone—psoriasis	4.93e-05	0.000241	CcSEcCtD
Cisplatin—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	4.93e-05	0.00048	CbGpPWpGaD
Cisplatin—Gastrointestinal disorder—Methotrexate—psoriasis	4.92e-05	0.00024	CcSEcCtD
Cisplatin—Asthenia—Prednisone—psoriasis	4.89e-05	0.000239	CcSEcCtD
Cisplatin—Pain—Methotrexate—psoriasis	4.87e-05	0.000238	CcSEcCtD
Cisplatin—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	4.87e-05	0.000474	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DRB1—psoriasis	4.81e-05	0.000469	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—VEGFA—psoriasis	4.75e-05	0.000463	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—STAT3—psoriasis	4.71e-05	0.000459	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.71e-05	0.000459	CbGpPWpGaD
Cisplatin—Feeling abnormal—Methotrexate—psoriasis	4.7e-05	0.000229	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—psoriasis	4.67e-05	0.000228	CcSEcCtD
Cisplatin—Nausea—Dexamethasone—psoriasis	4.65e-05	0.000227	CcSEcCtD
Cisplatin—Nausea—Betamethasone—psoriasis	4.65e-05	0.000227	CcSEcCtD
Cisplatin—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	4.64e-05	0.000453	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ICAM1—psoriasis	4.61e-05	0.00045	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NFKBIA—psoriasis	4.58e-05	0.000446	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—NDUFA5—psoriasis	4.56e-05	0.000444	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—NDUFA5—psoriasis	4.51e-05	0.000439	CbGpPWpGaD
Cisplatin—Body temperature increased—Methotrexate—psoriasis	4.51e-05	0.00022	CcSEcCtD
Cisplatin—GSTP1—Metabolism—CARM1—psoriasis	4.44e-05	0.000433	CbGpPWpGaD
Cisplatin—Vomiting—Prednisone—psoriasis	4.34e-05	0.000212	CcSEcCtD
Cisplatin—NQO1—Metabolism—CARM1—psoriasis	4.33e-05	0.000422	CbGpPWpGaD
Cisplatin—Rash—Prednisone—psoriasis	4.3e-05	0.00021	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—psoriasis	4.3e-05	0.00021	CcSEcCtD
Cisplatin—BCHE—Metabolism—CYP2S1—psoriasis	4.29e-05	0.000418	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	4.23e-05	0.000413	CbGpPWpGaD
Cisplatin—Hypersensitivity—Methotrexate—psoriasis	4.2e-05	0.000205	CcSEcCtD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	4.19e-05	0.000408	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—psoriasis	4.12e-05	0.000401	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.11e-05	0.000401	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	4.1e-05	0.000399	CbGpPWpGaD
Cisplatin—Asthenia—Methotrexate—psoriasis	4.09e-05	0.0002	CcSEcCtD
Cisplatin—Nausea—Prednisone—psoriasis	4.05e-05	0.000198	CcSEcCtD
Cisplatin—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	4.04e-05	0.000394	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	4e-05	0.00039	CbGpPWpGaD
Cisplatin—Diarrhoea—Methotrexate—psoriasis	3.9e-05	0.00019	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—IFNG—psoriasis	3.89e-05	0.00038	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CARM1—psoriasis	3.88e-05	0.000378	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP2S1—psoriasis	3.87e-05	0.000378	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—APOE—psoriasis	3.87e-05	0.000378	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP2S1—psoriasis	3.83e-05	0.000374	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IFNG—psoriasis	3.81e-05	0.000371	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.8e-05	0.00037	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL6—psoriasis	3.77e-05	0.000367	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TYK2—psoriasis	3.75e-05	0.000365	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CARM1—psoriasis	3.72e-05	0.000363	CbGpPWpGaD
Cisplatin—Vomiting—Methotrexate—psoriasis	3.62e-05	0.000177	CcSEcCtD
Cisplatin—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	3.62e-05	0.000353	CbGpPWpGaD
Cisplatin—Rash—Methotrexate—psoriasis	3.59e-05	0.000175	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—TP53—psoriasis	3.59e-05	0.00035	CbGpPWpGaD
Cisplatin—Dermatitis—Methotrexate—psoriasis	3.59e-05	0.000175	CcSEcCtD
Cisplatin—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.54e-05	0.000345	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFNG—psoriasis	3.51e-05	0.000342	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—NDUFA5—psoriasis	3.47e-05	0.000339	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.46e-05	0.000337	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.45e-05	0.000337	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD4—psoriasis	3.39e-05	0.00033	CbGpPWpGaD
Cisplatin—Nausea—Methotrexate—psoriasis	3.39e-05	0.000165	CcSEcCtD
Cisplatin—GSTT1—Metabolism—PPARG—psoriasis	3.37e-05	0.000329	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—NDUFA5—psoriasis	3.34e-05	0.000325	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.32e-05	0.000324	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL6—psoriasis	3.29e-05	0.00032	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.24e-05	0.000316	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—psoriasis	3.24e-05	0.000316	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CARM1—psoriasis	3.23e-05	0.000314	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CAT—psoriasis	3.21e-05	0.000313	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	3.19e-05	0.000311	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—ACE—psoriasis	3.13e-05	0.000305	CbGpPWpGaD
Cisplatin—MT2A—Immune System—JUN—psoriasis	3.03e-05	0.000296	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.02e-05	0.000294	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP2S1—psoriasis	2.95e-05	0.000288	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.94e-05	0.000287	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NFKB1—psoriasis	2.92e-05	0.000285	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.91e-05	0.000284	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.87e-05	0.00028	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP2S1—psoriasis	2.84e-05	0.000277	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CARM1—psoriasis	2.74e-05	0.000267	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CAT—psoriasis	2.73e-05	0.000266	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CAT—psoriasis	2.66e-05	0.000259	CbGpPWpGaD
Cisplatin—MT2A—Immune System—STAT3—psoriasis	2.63e-05	0.000256	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	2.57e-05	0.000251	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.56e-05	0.00025	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—psoriasis	2.52e-05	0.000246	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—APOE—psoriasis	2.5e-05	0.000243	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—psoriasis	2.46e-05	0.00024	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NDUFA5—psoriasis	2.46e-05	0.00024	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.45e-05	0.000239	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—psoriasis	2.45e-05	0.000238	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CAT—psoriasis	2.39e-05	0.000233	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NDUFA5—psoriasis	2.3e-05	0.000224	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.29e-05	0.000223	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CAT—psoriasis	2.29e-05	0.000223	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.29e-05	0.000223	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HLA-A—psoriasis	2.27e-05	0.000222	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.25e-05	0.000219	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—psoriasis	2.22e-05	0.000217	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.2e-05	0.000215	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.18e-05	0.000213	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PPARG—psoriasis	2.17e-05	0.000212	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.15e-05	0.000209	CbGpPWpGaD
Cisplatin—ABCC5—Disease—APOE—psoriasis	2.12e-05	0.000207	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—APOE—psoriasis	2.12e-05	0.000207	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CARM1—psoriasis	2.1e-05	0.000204	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000204	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—APOE—psoriasis	2.07e-05	0.000202	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—psoriasis	2.03e-05	0.000198	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2e-05	0.000195	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CAT—psoriasis	1.98e-05	0.000193	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOS2—psoriasis	1.98e-05	0.000193	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.96e-05	0.000191	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP2S1—psoriasis	1.96e-05	0.000191	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—LEP—psoriasis	1.94e-05	0.000189	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CARM1—psoriasis	1.89e-05	0.000184	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CARM1—psoriasis	1.87e-05	0.000182	CbGpPWpGaD
Cisplatin—XDH—Metabolism—APOE—psoriasis	1.85e-05	0.000181	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PPARG—psoriasis	1.85e-05	0.00018	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—psoriasis	1.83e-05	0.000179	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PPARG—psoriasis	1.8e-05	0.000176	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—APOE—psoriasis	1.78e-05	0.000173	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.71e-05	0.000167	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CAT—psoriasis	1.69e-05	0.000164	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.62e-05	0.000158	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TYK2—psoriasis	1.62e-05	0.000158	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PPARG—psoriasis	1.62e-05	0.000157	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.56e-05	0.000152	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PPARG—psoriasis	1.55e-05	0.000151	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.55e-05	0.000151	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—APOE—psoriasis	1.54e-05	0.00015	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.51e-05	0.000147	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—psoriasis	1.47e-05	0.000143	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CARM1—psoriasis	1.44e-05	0.000141	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.42e-05	0.000138	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CARM1—psoriasis	1.39e-05	0.000135	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.35e-05	0.000131	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—psoriasis	1.34e-05	0.000131	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—APOE—psoriasis	1.31e-05	0.000128	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—psoriasis	1.29e-05	0.000126	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CAT—psoriasis	1.29e-05	0.000126	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.22e-05	0.000118	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CAT—psoriasis	1.16e-05	0.000113	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CAT—psoriasis	1.15e-05	0.000112	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—psoriasis	1.14e-05	0.000111	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—psoriasis	1.13e-05	0.000111	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.07e-05	0.000104	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.03e-05	9.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CARM1—psoriasis	1.02e-05	9.97e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—APOE—psoriasis	1e-05	9.76e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CARM1—psoriasis	9.55e-06	9.31e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—APOE—psoriasis	9.04e-06	8.81e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—APOE—psoriasis	8.95e-06	8.72e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.93e-06	8.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CAT—psoriasis	8.87e-06	8.65e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HLA-A—psoriasis	8.82e-06	8.6e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—psoriasis	8.72e-06	8.5e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CAT—psoriasis	8.53e-06	8.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APOE—psoriasis	8.23e-06	8.02e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—psoriasis	7.93e-06	7.73e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—psoriasis	7.87e-06	7.67e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—psoriasis	7.79e-06	7.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOS2—psoriasis	7.67e-06	7.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APOE—psoriasis	6.89e-06	6.72e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOE—psoriasis	6.63e-06	6.46e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CAT—psoriasis	6.29e-06	6.13e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TYK2—psoriasis	6.28e-06	6.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—psoriasis	6.01e-06	5.85e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CAT—psoriasis	5.88e-06	5.73e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—psoriasis	5.77e-06	5.63e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—psoriasis	5.68e-06	5.54e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOE—psoriasis	4.89e-06	4.76e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOE—psoriasis	4.57e-06	4.45e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—psoriasis	4.4e-06	4.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—psoriasis	4.26e-06	4.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—psoriasis	3.98e-06	3.88e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—psoriasis	3.07e-06	3e-05	CbGpPWpGaD
